Inflammatory responses to intraocularly injected interleukin 1

Area of Science:

• Ophthalmology
• Immunology
• Inflammation Research

Background:

• Interleukin-1 (IL-1) is a key cytokine involved in inflammatory processes.
• The role of IL-1 in ocular inflammation, particularly its effect on the blood-aqueous barrier and chemoattraction, requires detailed investigation.

Purpose of the Study:

• To investigate the effects of intraocular interleukin-1 (IL-1) on the rabbit anterior chamber.
• To assess IL-1's impact on ocular blood vessels and the blood-aqueous barrier.
• To compare the chemoattractant potency of IL-1 with leukotriene B4.

Main Methods:

• Intraocular injection of purified human IL-1 into the anterior chamber of rabbit eyes.
• Monitoring of inflammatory cell accumulation at 4 and 24 hours post-injection.
• Examination of ocular blood vessels for abnormalities.
• Analysis of aqueous humor protein content to assess blood-aqueous barrier integrity.
• Comparative chemoattractant assays using IL-1 and leukotriene B4.

Main Results:

• Intraocular IL-1 induced significant inflammatory cell infiltration, peaking at 4 hours and persisting at 24 hours.
• No abnormalities were observed in ocular blood vessels following IL-1 injection.
• IL-1 did not alter aqueous humor protein levels, indicating no direct effect on the blood-aqueous barrier.
• IL-1 demonstrated significantly higher chemoattractant activity compared to leukotriene B4.

Conclusions:

• Intraocular IL-1 is a potent inducer of ocular inflammation and a strong chemoattractant for inflammatory cells.
• IL-1 does not appear to directly compromise the blood-aqueous barrier or affect ocular vasculature in this model.
• IL-1 is a considerably more potent chemoattractant than leukotriene B4 in the context of ocular inflammation.